Baxter International Inc. Share Price BOERSE MUENCHEN

Equities

BTL

US0718131099

Medical Equipment, Supplies & Distribution

Real-time BOERSE MUENCHEN 16:43:40 07/06/2024 BST 5-day change 1st Jan Change
30.66 EUR +0.02% Intraday chart for Baxter International Inc. -0.71% -13.14%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 15.11B 13.99B 1,188B Sales 2025 * 15.66B 14.5B 1,231B Capitalization 16.98B 15.71B 1,335B
Net income 2024 * 703M 651M 55.27B Net income 2025 * 950M 879M 74.68B EV / Sales 2024 * 1.77 x
Net Debt 2024 * 9.85B 9.11B 774B Net Debt 2025 * 9.06B 8.38B 712B EV / Sales 2025 * 1.66 x
P/E ratio 2024 *
18.1 x
P/E ratio 2025 *
14.9 x
Employees -
Yield 2024 *
3.58%
Yield 2025 *
3.72%
Free-Float 74.27%
More Fundamentals * Assessed data
Dynamic Chart
1 week-0.71%
Current month-1.81%
1 month-9.84%
3 months-21.89%
6 months-8.20%
Current year-13.14%
More quotes
1 week
30.20
Extreme 30.2
31.59
1 month
30.20
Extreme 30.2
34.01
3 years
29.50
Extreme 29.5
79.26
5 years
29.50
Extreme 29.5
87.10
10 years
26.43
Extreme 26.43
87.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 30/09/15
Director of Finance/CFO 54 17/10/23
Chief Tech/Sci/R&D Officer - 31/12/16
Members of the board TitleAgeSince
Director/Board Member 73 05/02/17
Director/Board Member 64 09/05/22
Director/Board Member 64 17/02/19
More insiders
Date Price Change
07/06/24 30.66 +0.02%
06/06/24 30.66 +1.44%
05/06/24 30.22 -1.66%
04/06/24 30.74 -1.91%
03/06/24 31.34 +0.35%

Real-time BOERSE MUENCHEN, June 07, 2024 at 04:43 pm

More quotes
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
33.32 USD
Average target price
45.44 USD
Spread / Average Target
+36.37%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW